Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Black Diamond Therapeutics, Inc. - Common Stock (NQ:BDTX)

3.905 -0.275 (-6.58%)
Streaming Delayed Price Updated: 1:39 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Black Diamond Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Black Diamond Therapeutics Stock is Shooting Higher Today: Here's Why
Black Diamond Therapeutics Inc (NASDAQ: BDTX) announced initial  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Recap: Black Diamond Therapeutic Q1 Earnings
Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Black Diamond Therapeutics to Present at the Stifel 2023 Targeted Oncology Days
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Black Diamond Therapeutics Presents Trial in Progress Poster for BDTX-1535 and Preclinical Data on BDTX-1535 and BDTX-4933 at the 2023 American Association of Cancer Research Annual Meeting
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Black Diamond Therapeutics Announces Changes to Board of Directors
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Black Diamond Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
$3 Million Bet On Taysha Gene Therapies? Check Out These 3 Penny Stocks Insiders Are Buying
The Dow Jones closed lower by more than 500 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Black Diamond Therapeutics And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by more than 100 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535 and BDTX-4933 at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
$1.8 Million Bet On MacroGenics? Check Out These 3 Penny Stocks Insiders Are Buying
The Dow Jones traded higher by over 400 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket
Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 80.1% to $0.4161 in pre-market trading after declining around 7% on Thursday. CONNEXA, last month, announced a $5.0 million private... 
Via Benzinga
Black Diamond Therapeutic: Q2 Earnings Insights
  Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
$1 Million Bet On CalAmp? 4 Penny Stocks Insiders are Buying
U.S. stocks opened slightly lower on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... 
Via Benzinga
Black Diamond Therapeutic: Q1 Earnings Insights
Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:30 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Executives Buy Around $1.6M Of 4 Penny Stocks
US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... 
Via Benzinga
Black Diamond Cuts 30% Of Its Workforce, Discontinues Drug From its 'MasterKey' Pipeline
Black Diamond Therapeutics Inc (NASDAQ: BDTX) is realigning its resources to extend its cash runway into the third quarter of 2024. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.